Thirty-year clinical experience in gamma knife radiosurgery for trigeminal schwannomas

Sci Rep. 2022 Aug 23;12(1):14357. doi: 10.1038/s41598-022-18689-5.

Abstract

We aimed to evaluate the radiographic and clinical outcomes after gamma knife radiosurgery (GKRS) for trigeminal schwannomas (TSs). A total of 87 patients who underwent GKRS for TSs between 1990 and 2020 were enrolled. The mean tumor volume was 4.3 cm3. The median prescribed dose for the margins of the tumor was 13 Gy. The median follow-up duration was 64.3 months (range 12.0-311.5 months). The overall local tumor control rate was 90%, and the symptom response rate was 93%. The response rate for each symptom was 88% for facial pain, 97% for facial sensory change, and 86% for cranial nerve deficits. Nineteen (22%) patients showed transient swelling, which had regressed at the time of the last follow-up. Cystic tumors were associated with transient swelling (p = 0.04). A tumor volume of < 2.7 cm3 was associated with local tumor control in univariable analysis. Transient swelling was associated with symptom control failure in both univariable and multivariable analyses (p = 0.04, odds ratio 14.538). GKRS is an effective treatment for TSs, both for local control and symptom control.

Publication types

  • Evaluation Study

MeSH terms

  • Cranial Nerve Neoplasms / diagnostic imaging
  • Cranial Nerve Neoplasms / radiotherapy
  • Cranial Nerve Neoplasms / surgery*
  • Facial Pain / radiotherapy
  • Facial Pain / surgery
  • Follow-Up Studies
  • Humans
  • Neurilemmoma / diagnostic imaging
  • Neurilemmoma / radiotherapy
  • Neurilemmoma / surgery*
  • Radiosurgery / instrumentation*
  • Retrospective Studies
  • Treatment Outcome
  • Trigeminal Nerve Diseases / diagnostic imaging
  • Trigeminal Nerve Diseases / radiotherapy
  • Trigeminal Nerve Diseases / surgery*
  • Tumor Burden